Incarceration is a major risk factor for blood-borne infection among intravenous drug users

Authors

Mohammad Mehdi Mir-Nasseri1, Ashraf MohammadKhani1, Hamid Tavakkoli2, Esmaeil Ansari1, Hossein Poustchi3,*
1Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2Al-Zahra University Hospital, Department of Gastroenterology, Isfahan University of Medical Sciences, Isfahan, IR Iran
3Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, [email protected], Tehran, IR Iran
*Corresponding Author: Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, [email protected], Tehran, IR Iran. Tel: +98-21-8802-6481. Fax: +98-8833-5062. Email: [email protected]

Hepatitis Monthly:Vol. 11, issue 1; 19-22
Published online:Jan 31, 2011
Article type:Research Article
Received:Jul 21, 2010
Accepted:Aug 27, 2010
How to Cite:Mir-Nasseri M, MohammadKhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users. Hepat Mon. 2011;11(1):. doi:

Abstract

Background: There is a strong association between hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infection which are mainly transmitted by contamination with blood via intravenous drug abuse (IVDU) or sexual contact.
Objectives: To determine the prevalence of these infections and the risk factors associated with them among prisoner and non-prisoner IVDUs in Tehran, Iran.
Patients and Methods: This cross-sectional study was performed in two jails and three drug rehabilitation centers between 2001 and 2002 in Tehran. HBsAg and HBcAb were checked using highly specific third generation enzyme immunoassays (DIA.PRO, Italy, specificity >99%, and Radim, Italy, specificity 99.7%, respectively). HCVAb was detected using ELISA (DIA.PRO, Italy) with both sensitivity and specificity >98%. HIVAb test (DRG Diagnostics kit, Germany) was performed for 459 of the 468 IDU subjects.
Results: 392 prisoners and 135 individual attending drug rehabilitation centers were approached. Of the 518 subjects studied, 464 (89.5%) were male, 386 (74.5%) were prisoners and 132 (25.5%) were non-prisoners. In this study, HBsAg, HCVAb and HIVAb were positive in 19 (3.7%), 359 (69.5%) and 70 (15.5%) of subjects, respectively. These tests were positive in 17 (4.5%), 311 (80.5%) and 63 (17%) among prisoners and 2 (1.5%), 48 (36.5%) and 7 (7.8%) in non-prisoners, respectively. Multiple logistic regression analysis revealed that independent factors related to co-infection of HCV and HIV infection were imprisonment (p<0.001. OR: 7.5) and using common syringe (p=0.03, OR: 4.5).
Conclusions: Our findings strongly suggest that drug injection inside prison carries is a risk for HIV infection and that HIV infection among IDUs is likely to be bridged to the broader population through sexual contact without using effective prevention programs.

  • Implication for Health policy/practice/research/medical education:
    Past history of being in a prison is discussed as one of the risk factors of acquiring Hepatitis B infection especially among IV drug abusers. Family physicians, health policy makers, authorized person in the health system of prisons should read this important article. Besides, this should be more considered for NGO's which are active for improvement of health conditions in the public places like prisons.
  • Please cite this paper as:
    Mir-Nasseri MM, MohammadKhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intrave¬nous drug users. Hepat Mon. 2011;11(1):19-22.

2011 Kowsar M.P.Co. All rights reserved.

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

20
Jan
2015

Prevalence of Co-Infections of Hepatitis B and C Among Drug Abuse: Prisoners and Its Association With High Risk Behavior

Behrooz Ataei,
Payman Adibi,
Zary Nokhodian,
Marjan Meshkati,
Zahra Boroumandfar

Ataei B, Adibi P, Nokhodian Z, Meshkati M, Boroumandfar Z. Prevalence of Co-Infections of Hepatitis B and C Among Drug Abuse: Prisoners and Its Association With High Risk Behavior. Jundishapur J Chronic Dis Care. 2015;4(1):e26620. doi: https://doi.org/10.5812/jjcdc.26620

31
Mar
2010

Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008

Gholamreza Sharifzadeh,
Zohre Azarkar

Sharifzadeh G, Azarkar Z. Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008. Hepat Mon. 2010;10(1):. doi:

13
Feb
2016

The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey

Derya Keten,
Mehmet Emin Ova,
Hamit Sirri Keten,
Alper Keten,
Evrim Gulderen,
Seray Tumer
,et al.

Keten D, Emin Ova M, Sirri Keten H, Keten A, Gulderen E, et al. The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey. Jundishapur J Microbiol. 2016;9(2):e31598. doi: https://doi.org/10.5812/jjm.31598

21
Jul
2019
Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016

Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016

Ghobad Moradi,
Saeede Jafari,
Bushra Zarei,
Marzieh Mahboobi,
Fatemeh Azimian Zavareh,
Leila Molaeipoor
,et al.

Moradi G, Jafari S, Zarei B, Mahboobi M, Azimian Zavareh F, et al. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016. Hepat Mon. 2019;19(7):e91129. doi: https://doi.org/10.5812/hepatmon.91129

1
Aug
2013

Prevalence and Risk Factors of Hepatitis B Virus Genotype D Amongst Inmates in Alborz Province, Iran: A Cross-Sectional Survey

Fatemeh Salem,
Soheila Hekmat,
Mohammad Reza Aghasadeghi,
Foozieh Javadi,
Hossein Gholami,
Ehsan Mostafavi

Salem F, Hekmat S, Aghasadeghi MR, Javadi F, Gholami H, et al. Prevalence and Risk Factors of Hepatitis B Virus Genotype D Amongst Inmates in Alborz Province, Iran: A Cross-Sectional Survey. Jundishapur J Microbiol. 2013;6(6):e10221. doi: https://doi.org/10.5812/jjm.10221

More by these authors

Mohammad Mir-NasseriPubMedScholar
Ashraf MohammadKhaniPubMedScholar
Hamid TavakkoliPubMedScholar
Esmaeil AnsariPubMedScholar
Hossein PoustchiPubMedScholar
Share
Cited by
Metrics